The United States is facing a historic crisis over fentanyl, while Trump is reactivating his war on drugs with a punitive strategy that puts pressure on Latin America and relegates prevention.
The proliferation of clandestine laboratories and the lack of regulation in the pharmaceutical industry have contributed to the gradual emergence of new synthetic drugs in the region.
The announcement by the U.S. Department of Justice is a jolt for the Mexican government. However, for the moment, it does not affect the electoral situation.
Co-author Jaime Arredondo
The pandemic has negatively affected substance users particularly in the U.S.-Mexico border region, where traffickers, wholesale buyers, retailers, and consumers converge.
